Abstract
P513 Efficacy of vedolizumab in ulcerative colitis by prior treatment failure in GEMINI I, a randomised, placebo-controlled, double-blind, multi-centre trial B. Feagan1 *, B. Sands2, S. Sankoh3, C. Milch3, I. Fox3. 1Robarts Research Institute, University of Western Ontario, London, Canada, 2Mount Sinai School of Medicine, Division of Gastroenterology, New York, United States, 3Millennium Pharmaceuticals, Inc., Cambridge, United States
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
